Literature DB >> 29293969

Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.

Viviany R Taqueti1, Scott D Solomon1, Amil M Shah1, Akshay S Desai2, John D Groarke2, Michael T Osborne3, Jon Hainer1, Courtney F Bibbo1, Sharmila Dorbala1, Ron Blankstein1, Marcelo F Di Carli1.   

Abstract

Aims: Coronary microvascular ischaemia, cardiomyocyte injury and stiffness may play an important role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). To date, the relationship between coronary flow reserve (CFR), myocardial injury, diastolic dysfunction, and future HFpEF risk is unknown. Methods and results: Consecutive patients (n = 201) undergoing evaluation for suspected coronary artery disease (CAD) with stress myocardial perfusion positron emission tomography, serum troponin, and transthoracic echocardiography who did not have flow-limiting CAD or reduced left ventricular ejection fraction were identified. Patients were followed up (median 4.1 years) for cardiovascular death and hospitalization for non-fatal myocardial infarction or heart failure. Coronary flow reserve was quantified as stress/rest myocardial blood flow. Early diastolic flow (E) and relaxation (e') velocities were obtained via transmitral and tissue Doppler, respectively. Patients with impaired CFR (<2, n = 108) demonstrated linearly decreasing e' and increasing E/e' consistent with worsening diastolic function (P for trend <0.0001). A detectable troponin was associated with diastolic dysfunction only in the presence of impaired CFR (interaction P = 0.002). In adjusted analyses, impaired CFR was independently associated with diastolic dysfunction (E/e'septal > 15, adjusted OR 2.58, 95%CI 1.22-5.48) and composite cardiovascular outcomes or HFpEF hospitalization alone (adjusted HR 2.47, 95%CI 1.09-5.62). Patients with both impaired CFR and diastolic dysfunction demonstrated >five-fold increased risk of HFpEF hospitalization (P < 0.001).
Conclusion: In symptomatic patients without overt CAD, impaired CFR was independently associated with diastolic dysfunction and adverse events, especially HFpEF hospitalization. The presence of both coronary microvascular and diastolic dysfunctions was associated with a markedly increased risk of HFpEF events.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29293969      PMCID: PMC5939665          DOI: 10.1093/eurheartj/ehx721

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  31 in total

1.  Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction.

Authors:  Kajenny Srivaratharajah; Thais Coutinho; Robert deKemp; Peter Liu; Haissam Haddad; Ellamae Stadnick; Ross A Davies; Sharon Chih; Girish Dwivedi; Ann Guo; George A Wells; Jordan Bernick; Robert Beanlands; Lisa M Mielniczuk
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

2.  ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.

Authors:  Vasken Dilsizian; Stephen L Bacharach; Rob S Beanlands; Steven R Bergmann; Dominique Delbeke; Sharmila Dorbala; Robert J Gropler; Juhani Knuuti; Heinrich R Schelbert; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2016-07-08       Impact factor: 5.952

Review 3.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.

Authors:  C Noel Bairey Merz; Carl J Pepine; Mary Norine Walsh; Jerome L Fleg
Journal:  Circulation       Date:  2017-03-14       Impact factor: 29.690

4.  Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.

Authors:  Viviany R Taqueti; Rory Hachamovitch; Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-11-16       Impact factor: 29.690

5.  Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve.

Authors:  Ibrahim Danad; Pieter G Raijmakers; Roel S Driessen; Jonathon Leipsic; Rekha Raju; Chris Naoum; Juhani Knuuti; Maija Mäki; Richard S Underwood; James K Min; Kimberly Elmore; Wynand J Stuijfzand; Niels van Royen; Igor I Tulevski; Aernout G Somsen; Marc C Huisman; Arthur A van Lingen; Martijn W Heymans; Peter M van de Ven; Cornelis van Kuijk; Adriaan A Lammertsma; Albert C van Rossum; Paul Knaapen
Journal:  JAMA Cardiol       Date:  2017-10-01       Impact factor: 14.676

6.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.

Authors:  Lasse Jespersen; Anders Hvelplund; Steen Z Abildstrøm; Frants Pedersen; Søren Galatius; Jan K Madsen; Erik Jørgensen; Henning Kelbæk; Eva Prescott
Journal:  Eur Heart J       Date:  2011-09-11       Impact factor: 29.983

7.  Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Karl-Philipp Rommel; Maximilian von Roeder; Konrad Latuscynski; Christian Oberueck; Stephan Blazek; Karl Fengler; Christian Besler; Marcus Sandri; Christian Lücke; Matthias Gutberlet; Axel Linke; Gerhard Schuler; Philipp Lurz
Journal:  J Am Coll Cardiol       Date:  2016-04-19       Impact factor: 24.094

8.  Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.

Authors:  Torbjørn Omland; Marc A Pfeffer; Scott D Solomon; James A de Lemos; Helge Røsjø; Jūratė Šaltytė Benth; Aldo Maggioni; Michael J Domanski; Jean L Rouleau; Marc S Sabatine; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2013-02-13       Impact factor: 24.094

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

10.  Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine-Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Shingo Kato; Naka Saito; Hidekuni Kirigaya; Daiki Gyotoku; Naoki Iinuma; Yuka Kusakawa; Kohei Iguchi; Tatsuya Nakachi; Kazuki Fukui; Masaaki Futaki; Tae Iwasawa; Kazuo Kimura; Satoshi Umemura
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

View more
  137 in total

1.  Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.

Authors:  Omar F AbouEzzeddine; Bradley J Kemp; Barry A Borlaug; Brian P Mullan; Atta Behfar; Sorin V Pislaru; Marat Fudim; Margaret M Redfield; Panithaya Chareonthaitawee
Journal:  Circ Heart Fail       Date:  2019-10-15       Impact factor: 8.790

2.  Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium.

Authors:  Leslee J Shaw; James K Min; Khurram Nasir; Joe X Xie; Daniel S Berman; Michael D Miedema; Seamus P Whelton; Zeina A Dardari; Alan Rozanski; John Rumberger; C Noel Bairey Merz; Mouaz H Al-Mallah; Matthew J Budoff; Michael J Blaha
Journal:  Eur Heart J       Date:  2018-11-01       Impact factor: 29.983

3.  Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction.

Authors:  Senthil Selvaraj; Brian Claggett; Sanjiv J Shah; Inder Anand; Jean L Rouleau; Eileen O'Meara; Akshay S Desai; Eldrin F Lewis; Bertram Pitt; Nancy K Sweitzer; James C Fang; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2018-11       Impact factor: 8.790

Review 4.  Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging.

Authors:  Sadi Loai; Hai-Ling Margaret Cheng
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

5.  Creeping towards broader clinical application of PET myocardial blood flow quantification.

Authors:  Paul C Cremer; Frank P DiFilippo; Manuel D Cerqueira
Journal:  J Nucl Cardiol       Date:  2019-02-21       Impact factor: 5.952

6.  Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial).

Authors:  Stuart B Prenner; Anupam Kumar; Lei Zhao; Mary E Cvijic; Michael Basso; Thomas Spires; Zhuyin Li; Melissa Yarde; Priyanka Bhattacharya; Payman Zamani; Jeremy Mazurek; Zhaoqing Wang; Dietmar Seiffert; David A Gordon; Julio A Chirinos
Journal:  Am J Cardiol       Date:  2019-11-19       Impact factor: 2.778

7.  Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.

Authors:  Navkaranbir S Bajaj; Amitoj Singh; Wunan Zhou; Ankur Gupta; Kana Fujikura; Christina Byrne; Hendrik J Harms; Michael T Osborne; Paco Bravo; Efstathia Andrikopolou; Sanjay Divakaran; Courtney F Bibbo; Jon Hainer; Hicham Skali; Viviany Taqueti; Michael Steigner; Sharmila Dorbala; David M Charytan; Sumanth D Prabhu; Ron Blankstein; Rahul C Deo; Scott D Solomon; Marcelo F Di Carli
Journal:  Circulation       Date:  2019-11-29       Impact factor: 29.690

8.  Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.

Authors:  Navkaranbir S Bajaj; Michael T Osborne; Ankur Gupta; Ali Tavakkoli; Paco E Bravo; Tomas Vita; Courtney F Bibbo; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Deepak L Bhatt; Marcelo F Di Carli; Viviany R Taqueti
Journal:  J Am Coll Cardiol       Date:  2018-08-14       Impact factor: 24.094

Review 9.  Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.

Authors:  Islam Y Elgendy; Dhruv Mahtta; Carl J Pepine
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

10.  Endothelial sodium channel activation promotes cardiac stiffness and diastolic dysfunction in Western diet fed female mice.

Authors:  James R Sowers; Javad Habibi; Guanghong Jia; Brian Bostick; Camila Manrique-Acevedo; Guido Lastra; Yan Yang; Dongqing Chen; Zhe Sun; Timothy L Domeier; William Durante; Adam T Whaley-Connell; Michael A Hill; Frederic Jaisser; Vincent G DeMarco; Annayya R Aroor
Journal:  Metabolism       Date:  2020-04-07       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.